Based on current rates, U.S. government investment in life sciences research is likely to be only one quarter of China's on a per-GDP basis in the next five years.

Though life science is widely assumed to be a strong sector for the U.S., if current budget cuts continue, emerging nations such as China will overtake the U.S as the world's leader in this area. Policymakers must realize the importance of boosting public investments in life sciences for U.S. prosperity and international competitiveness and the tremendous societal value of advances in this area. We can and must avoid the peril of falling behind in this critical sector.